for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Zimmer Biomet Holdings Inc

ZBH

Latest Trade

166.38USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

112.00

 - 

180.36

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
166.38
Open
--
Volume
--
3M AVG Volume
23.13
Today's High
--
Today's Low
--
52 Week High
180.36
52 Week Low
112.00
Shares Out (MIL)
208.48
Market Cap (MIL)
34,082.65
Forward P/E
20.79
Dividend (Yield %)
0.59

Next Event

Dividend For ZBH.N - 0.2400 USD

Latest Developments

More

Zimmer Biomet Reports Q1 EPS $0.94

Zimmer Biomet Announces Changes To Company's Board Of Directors

Zimmer Biomet Announces Intent To Spin Off Spine And Dental Businesses

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.

Industry

Medical Equipment & Supplies

Contact Info

345 E Main St

WARSAW, IN

46580-2746

United States

+1.574.2676131

http://www.zimmerbiomet.com/

Executive Leadership

Bryan C. Hanson

Chairman of the Board, President, Chief Executive Officer

Suketu P. Upadhyay

Chief Financial Officer, Executive Vice President

Wilfred Van Zuilen

President - Europe, Middle East and Africa

Sang Yi

President, Asia Pacific

Ivan Tornos

Chief Operating Officer

Key Stats

1.79 mean rating - 29 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

7.9K

2019

8.0K

2020

7.0K

2021(E)

8.1K
EPS (USD)

2018

7.640

2019

7.870

2020

5.670

2021(E)

7.864
Price To Earnings (TTM)
60.24
Price To Sales (TTM)
4.81
Price To Book (MRQ)
2.74
Price To Cash Flow (TTM)
21.07
Total Debt To Equity (MRQ)
62.99
LT Debt To Equity (MRQ)
60.58
Return on Investment (TTM)
2.61
Return on Equity (TTM)
2.30

Latest News

Latest News

BRIEF-Zimmer Biomet Holdings Sets Quarterly Cash Dividend Of $0.24 Per Share

* SETS QUARTERLY CASH DIVIDEND OF $0.24PER SHARE Source text for Eikon: Further company coverage:

BRIEF-Conformis Says Zimmer Biomet Required To Pay Co $3.5 Mln Within 30 Days

* CONFORMIS - ZIMMER IS REQUIRED TO PAY CONFORMIS $3.5 MILLION WITHIN 30 DAYS

BRIEF-Zimmer Biomet Reports First Quarter 2020 Financial Results

* ZIMMER BIOMET ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS

BRIEF-Zimmer Biomet Holdings On April 23 Entered Into A Revolving Credit Agreement

* ZIMMER BIOMET HOLDINGS INC - ON APRIL 23 ENTERED INTO A REVOLVING CREDIT AGREEMENT

BRIEF-Zimmer Biomet Holdings Says Withdrawing Full-Year Financial Guidance It Previously Issued On February 4

* ZIMMER BIOMET HOLDINGS INC - WITHDRAWING FULL-YEAR FINANCIAL GUIDANCE IT PREVIOUSLY ISSUED ON FEBRUARY 4, 2020

IN BRIEF: En banc 3rd Circuit won’t block design-defect suit against Zimmer Biomet  

The full 3rd U.S. Circuit Court of Appeals on Tuesday let stand a panel decision that revived a Pennsylvania woman’s claims that her Zimmer Biomet hip implant was defectively designed.

Jury must decide when plaintiff had notice of claim v. Zimmer Biomet – 3rd Circuit

A divided federal appeals court on Wednesday revived a Pennsylvania woman’s design-defect lawsuit over a Zimmer Biomet hip implant, vacating a lower-court judge’s ruling that the complaint was filed too late.

Appeals court upholds $254 million patent verdict for Stryker against Zimmer

A federal appeals court on Monday upheld a $254 million patent infringement verdict Stryker Corp won against rival medical device maker Zimmer Biomet Holdings Inc, bringing a likely end to a long-running court battle that previously ended up before the U.S. Supreme Court.

Sales reps can pursue overtime lawsuit against Zimmer Biomet - ruling

Medical device maker Zimmer Biomet must face a lawsuit accusing it of denying overtime pay to sales representatives across the country by misclassifying them as independent contractors, a federal judge in San Francisco ruled.

Hip and knee surgeons to use Apple Watch to monitor patients

Up to 10,000 Americans due to have hip or knee replacements will be able to funnel basic health data directly from their Apple Watches to their surgeons under a new app being tested by orthopedics company Zimmer Biomet.

Hip and knee surgeons to use Apple Watch to monitor patients

Up to 10,000 Americans due to have hip or knee replacements will be able to funnel basic health data directly from their Apple Watches to their surgeons under a new app being tested by prosthetic limb specialist Zimmer Biomet .

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up